» Articles » PMID: 30018513

Presurgical Identification of Uterine Smooth Muscle Malignancies Through the Characteristic FDG Uptake Pattern on PET Scans

Overview
Specialty Radiology
Date 2018 Jul 19
PMID 30018513
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The unidentified presence of uterine smooth muscle malignancies poses a tremendous risk in women planning surgery for presumed benign leiomyomas. We sought to investigate whether preoperative FDG PET may be useful to identify leiomyosarcomas (LMS) and smooth muscle tumors of uncertain malignant potential (STUMP). . We investigated patients with rapidly growing uterine masses which were suspected of being malignant on ultrasound or MRI. Among the 21 patients who underwent FDG PET, we identified 7 LMS, 1 STUMP, and 13 leiomyomas. PET-derived parameters and FDG uptake patterns were analyzed retrospectively. . The SUV values of LMS/STUMP (range: 3.7-11.8) were significantly higher than those observed in leiomyomas (range: 2.0-9.4; =0.003) despite a significant overlap. The metabolic tumor/necrosis ratio was significantly higher in LMS/STUMP than in leiomyomas ( < 0.001), with no significant intergroup overlaps. All LMS/STUMP revealed a characteristic pattern of FDG uptake, identifying a specific "hollow ball" sign (corresponding to areas of coagulative tumor necrosis). In contrast, this sign was invariably absent in patients with leiomyomas. . The characteristic FDG uptake pattern instead of SUV on PET images allows identifying LMS/STUMP in patients with rapidly growing uterine masses, avoiding the deleterious consequences of regular surgery for presumed benign leiomyomas.

Citing Articles

Uterine Smooth Muscle Tumor of Undetermined Malignant Potential (STUMP): A Diagnostic Challenge.

Jena S, Sinha N, Mishra M, Singh V, Upadhyay A Cureus. 2024; 16(11):e73115.

PMID: 39651034 PMC: 11622332. DOI: 10.7759/cureus.73115.


Ultrasound Appearance of Intravascular Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Case Report.

Montik N, Grelloni C, Filosa A, Goteri G, Di Giuseppe J, Natalini L Diagnostics (Basel). 2024; 14(13).

PMID: 39001332 PMC: 11241662. DOI: 10.3390/diagnostics14131438.


Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Comprehensive Multidisciplinary Update.

Tinelli A, DOria O, Civino E, Morciano A, Hashmi A, Baldini G Medicina (Kaunas). 2023; 59(8).

PMID: 37629661 PMC: 10456637. DOI: 10.3390/medicina59081371.


A Review and Follow-Up of Uterine Smooth Muscle Tumours of Uncertain Malignant Potential (STUMP): A Case Series and Literature Review.

Lapresa-Alcalde M, Ruiz-Navarro M, Sancho de Salas M, Cubo A Diseases. 2023; 11(3).

PMID: 37606470 PMC: 10443286. DOI: 10.3390/diseases11030099.


Uterine smooth muscle tumors with uncertain malignant potential: analysis following fertility-saving procedures.

Richtarova A, Boudova B, Dundr P, Lisa Z, Hlinecka K, Zizka Z Int J Gynecol Cancer. 2023; 33(5):701-706.

PMID: 36898699 PMC: 10176401. DOI: 10.1136/ijgc-2022-004038.


References
1.
Gockley A, Rauh-Hain J, Carmen M . Uterine leiomyosarcoma: a review article. Int J Gynecol Cancer. 2014; 24(9):1538-42. DOI: 10.1097/IGC.0000000000000290. View

2.
Cornfeld D, Israel G, Martel M, Weinreb J, Schwartz P, McCarthy S . MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol. 2009; 74(1):241-9. DOI: 10.1016/j.ejrad.2009.03.005. View

3.
Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I . Clinical management of uterine sarcomas. Lancet Oncol. 2009; 10(12):1188-98. DOI: 10.1016/S1470-2045(09)70226-8. View

4.
Ho K, Lai C, Wu T, Ng K, Yen T, Lin G . 18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma. Eur J Nucl Med Mol Imaging. 2007; 35(3):484-92. DOI: 10.1007/s00259-007-0533-z. View

5.
Bell S, Kempson R, Hendrickson M . Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994; 18(6):535-58. View